Kinnate Biopharma, Inc.
(NASDAQ : KNTE)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.06%36.720.9%$1162.21m
JNJJohnson & Johnson 1.42%162.580.7%$1092.50m
LLYEli Lilly & Co. 3.43%197.321.1%$727.56m
ABBVAbbVie, Inc. 1.03%111.661.9%$710.61m
MRKMerck & Co., Inc. -0.25%83.180.7%$682.27m
BMYBristol-Myers Squibb Co. -0.06%66.501.0%$677.21m
AZNAstraZeneca Plc 2.23%52.491.2%$644.28m
ARCTArcturus Therapeutics Holdings, Inc. 12.81%67.340.0%$231.55m
VTRSViatris, Inc. 1.81%17.360.0%$195.54m
RPRXRoyalty Pharma Plc 1.40%52.680.2%$176.33m
NVSNovartis AG 1.04%96.630.2%$172.41m
GSKGlaxoSmithKline Plc 0.07%38.500.2%$140.32m
SNYSanofi 1.82%50.290.2%$115.85m
RGENRepligen Corp. 2.83%221.586.9%$77.79m
NVONovo Nordisk A/S 0.96%72.720.1%$71.51m

Company Profile

Kinnate Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.